Qualifications
Responsibilities
Benefits
For candidates seeking to be located at our Stevenage site, this role will temporarily be based at Stevenage. However, the Company plans to relocate its offices to Cambridge, UK. The location of this role will therefore subsequently change to Cambridge, UK in accordance with timelines to be set by the Company. The relocation is currentlyproposed to take effect by early 2029.
With GSK's growing portfolio in GU (genitourinary) cancers, we have an exciting opportunity for a Clinical Development Lead (CDL) 6 Oncology GU. Operating at the asset level as the enterprise clinical strategy leader, you will be accountable for defining the clinical strategy, scientific narrative, and decision framework across the asset lifecycle. The CDL serves as a full strategic partner within the Medicine Development Team (MDT) core quad, positioning Clinical Development at the centre of product strategy, governance, and investment decisions.
The CDL owns the clinical roadmap and serves as the recognised clinical authority and visible leader for the asset 27s strategic vision, shaping how clinical strategy, scientific insight, development innovation, and decision velocity are understood and experienced across the organisation, representing Clinical Development in both internal and external settings. You will be accountable for the strategic direction and clinical positioning of the asset, with operational study-level delivery led by Senior Scientists within the programme. This role is critical to enabling a more dynamic, data-driven, and technology-enabled model of clinical development, increasing speed, precision, and decision quality.
In This Role You Will:
Define and own the clinical strategy, scientific narrative, integrated benefit 6risk position, and decision framework across the asset, ensuring a coherent and differentiated clinical position throughout the lifecycle
Accountable for strategic outcomes across the asset, with study-level delivery, including design, execution, and data generation, led by Senior Scientists and programme teams within the CDL 27s strategic direction
Serve as the senior clinical strategy leader on the MDT core quad, acting as a full strategic partner to the Medicine Development Leader (MDL) and representing Clinical Development in portfolio, governance, and investment decisions
Lead or co-lead governance and investment presentations to senior management, translating clinical evidence into clear strategic recommendations for portfolio prioritisation and progression
Serve as the recognised clinical authority and visible leader for the asset, ensuring its clinical vision, scientific identity, and development trajectory are clearly understood and advanced across the organisation
Drive an integrated, end-in-mind approach to development, ensuring that target selection, development pathways, regulatory positioning, and commercial readiness are considered as a connected whole
Act as the default Clinical Development representative for Health Authority interactions, advisory boards, steering committees, IDMCs, and alliance partnerships
Leverage AI-enabled insights, advanced analytics, and emerging data platforms to inform asset-level strategic decisions and drive competitive advantage in development speed and decision quality
Lead, develop, and mentor clinical development talent, contributing to talent calibration, succession planning, and capability building aligned to evolving development models
Key Responsibilities:
Enterprise Clinical Strategy and Governance
Serve as the senior clinical strategy leader on the MDT core quad, representing the voice of Clinical Development in portfolio, governance, and investment decisions
Own the clinical and scientific narrative for the asset, acting as the recognised clinical authority whose leadership is synonymous with the asset 27s clinical vision and development trajectory
Lead or co-lead governance and investment discussions, translating clinical evidence and benefit 6risk into strategic recommendations that inform portfolio prioritisation and resource allocation
Drive an integrated, end-in-mind approach to clinical strategy, moving beyond sequential development to ensure alignment across scientific, regulatory, and commercial considerations
Proactively engage enterprise stakeholders 6 including Medical Affairs, Integrated Evidence, Commercial, and Regulatory 6 to integrate perspectives, resolve trade-offs, and align on product strategy
Define the asset-level evidence-generation strategy, including how clinical data is prioritised and integrated across development, regulatory, and lifecycle decisions
Operate across the full asset lifecycle, integrating insights across studies and functions to ensure a coherent and differentiated clinical position
Clinical Development Plan and Benefit 6Risk Leadership
Accountable for the strategic integrity and clinical direction of the Clinical Development Plan (CDP), ensuring it reflects asset-level strategy and is delivered through programme teams
Own the integrated benefit 6risk framework, ensuring alignment between clinical data, safety insights, and strategic decision-making
Define the strategic direction and decision frameworks guiding study design and development approaches across the asset
Provide strategic direction to Senior Scientists on the content and scientific quality of CDP-associated deliverables, ensuring execution aligns with asset-level clinical intent
Leverage AI-enabled insights, advanced analytics, and emerging data platforms to inform asset-level strategic decisions, enhance the precision of programme direction, and strengthen the evidence base for governance and portfolio decisions
Ensure alignment between clinical strategy and programme-level execution, maintaining clarity of clinical intent across teams
Scientific Leadership and External Engagement
Serve as the default Clinical Development representative for Health Authority interactions, including scientific advice, regulatory meetings, and responses to queries
Provide strategic oversight and final clinical accountability for scientific communications derived from clinical data, including publications, congress presentations, and advisory materials
Represent Clinical Development across external engagements, including advisory boards, steering committees, IDMCs, and alliance partnerships
Synthesise integrated clinical insights and evidence trends to shape asset-level strategic direction and inform governance decisions
Shape and influence clinical development standards, governance practices, and decision-making frameworks across Oncology Clinical Development, ensuring consistency and quality at the programme level
People Leadership and Capability Development
Develop and mentor clinical development talentwithin the asset programme, ensuring the right people are in the right roles and that team capabilities are aligned with current and future development models
Contribute to talent calibration, succession planning, and resourcing decisions across the Oncology Clinical Development function
Set clear expectations for decision quality, accountability, and collaboration across the asset programme, empowering Senior Scientists and Clinical Matrix Teams to lead operational delivery within the CDL 27s strategic direction
Champion a culture of innovation, integrated thinking, and continuous improvement, reinforcing the enterprise mindset and technology fluency required for the evolving R6D operating model
Basic Qualifications:
Preferred Qualifications:
Closing date for applications: 31 October 2026
Working Arrangement
This role is hybrid. You will be on-site at one of the posted locations at least two days per week. Remote work is available on other days.
Apply now
If you are ready to make a real impact in clinical development and grow your career at GSK, we want to hear from you. Share your experience, your vision for the role, and how you will contribute to advancing patient care. We look forward to joining you on this journey.
Skills
Clinical Data Interpretation, Clinical Trial Designs, Clinical Trials Monitoring, Digital Fluency, Drug Development, Drug Regulatory Affairs, Evidence Based Decision Making, Executive Presence, Hematology and Oncology, Learning Agility, Matrix Leadership, Real World Evidence (RWE), Scientific Presentations, Strategic Direction If you are based in Cambridge, MA; Waltham, MA; Rockville, MD; or San Francisco, CA, the annual base salary for new hires in this position ranges $284,250 to $473,750. The US salary ranges take into account a number of factors including work location within the US market, the candidate 27s skills, experience, education level and the market rate for the role. In addition, this position offers an annual bonus and eligibility to participate in our share based long term incentive program which is dependent on the level of the role. Available benefits include health care and other insurance benefits (for employee and family), retirement benefits, paid holidays, vacation, and paid caregiver/parental and medical leave. If salary ranges are not displayed in the job posting for a specific country, the relevant compensation will be discussed during the recruitment process.In compliance with Ontario 27s provincial pay transparency legislation, this job posting includes a salary range to support equitable and informed hiring practices. The annual compensation for this role is CAD0 to CAD0 , determined based on experience, qualifications, and internal equity. GSK is dedicated to promoting transparency and fairness throughout our recruitment process.Salary ranges for other locations are shown because some markets have pay transparency laws that require salary information on job postings, and those locations are potential job sites for this role. If salary ranges are not displayed in the job posting for a specific location or country, the relevant compensation will be discussed during the recruitment process.Polish Salary Range / Polski przedzia2 wynagrodzenia: PLN 593,250 to PLN 988,750The annual gross base salary range for new hires in this position is listed above for each applicable location. These ranges take into account a number of factors including the candidate 27s skills, experience, education level and the market rate for the role. In addition, this position may offer an annual bonus and eligibility to participate in our share based long term incentive program which is dependent on the level of the role. More detailed information on the total benefits package will be supplied during the recruitment process. This role is available for applicants from multiple locations, and therefore salary ranges for certain locations are also shown. Salary ranges for other locations are shown because some markets have pay transparency laws that require salary information on job postings, and those locations are potential job sites for this role. If salary ranges are not displayed in the job posting for a specific location or country, the relevant compensation will be discussed during the recruitment process. Please note salaries vary by country based on the candidate 27s skills, experience, education level and the market rate for the role. Offers are typically made within the advertised range based on the candidate 27s skills, experience and qualifications, with the upper end generally reserved for highly experienced candidates or other exceptional circumstances aligned with these criteria.Please visit GSK US Benefits Summary to learn more about the comprehensive benefits program GSK offers US employees.
Our team will look into this right away.
